New Intermittent Urinary Micro-Hole Zone Catheter Shows Enhanced Performance in Emptying the Bladder: A Randomised, Controlled Crossover Study
- PMID: 37629309
- PMCID: PMC10455232
- DOI: 10.3390/jcm12165266
New Intermittent Urinary Micro-Hole Zone Catheter Shows Enhanced Performance in Emptying the Bladder: A Randomised, Controlled Crossover Study
Abstract
Urinary tract infections (UTIs) are common and troublesome complications of clean intermittent catheterisation (CIC) in individuals suffering from incomplete bladder emptying, which may exacerbate the underlying disease and lead to hospitalisation. Aside from the design of the intermittent catheter and its handling, a recent review highlighted residual urine as one of several UTI risk factors. A new urinary intermittent catheter with multiple micro-holes has been developed for improved bladder emptying. In a controlled crossover study, adult male CIC users were randomised for a health care professional-led catheterisation with the new micro-hole zone catheter (MHZC) and a conventional eyelet catheter (CEC) in two individual test visits to compare the number of flow-stops and the residual urine at the first flow-stop as co-primary endpoints. In 42 male CIC users, the MHZC resulted in significantly fewer flow-stop episodes compared to the CEC (mean 0.17, 95% CI [0.06, 0.45] vs. mean 1.09, 95% CI [0.75, 1.6], respectively; p < 0.001) and significantly less residual urine at the first flow-stop (mean 5.10 mL, SE [1.14] vs. mean 39.40 mL, SE [9.65], respectively; p < 0.001). No adverse events were observed in this study. The results confirm the enhanced performance of the MHZC compared to a CEC, ensuring an uninterrupted free urine flow with no need to reposition the catheter until the bladder is thoroughly empty.
Keywords: intermittent urethral catheterisation; micro-hole drainage zone; urinary bladder disease; urinary flow-stop; urinary retention; urinary tract infection.
Conflict of interest statement
The study was financially supported by Coloplast A/S. Cecilie Rovsing was paid a fixed price by Coloplast to conduct the study and took part in reviewing the manuscript. Michael Kennelly has received honoraria for participating in a Coloplast NeuroUrology Advisory Board and took part in the design of the study and review of the manuscript. Malene Hornbak Landauro, Lotte Jacobsen, Fabio Tentor, Troels Pedersen, and Omar Feix do Nascimento were Coloplast A/S employees during the study, and all took part in the interpretation and writing of the manuscript.
Figures





References
-
- Theisen K.M., Mann R., Roth J.D., Pariser J.J., Stoffel J.T., Lenherr S.M., Myers J.B., Welk B., Elliott S.P. Frequency of patient-reported UTIs is associated with poor quality of life after spinal cord injury: A prospective observational study. Spinal Cord. 2020;58:1274–1281. doi: 10.1038/s41393-020-0481-z. - DOI - PubMed
-
- Welk B., Lenherr S., Santiago-Lastra Y., Norman H.S., Keiser M.G., Elliott C.S. Differences in the incidence of urinary tract infections between neurogenic and non-neurogenic bladder dysfunction individuals performing intermittent catheterization. Neurourol. Urodyn. 2022;41:1002–1011. doi: 10.1002/nau.24914. - DOI - PubMed
-
- Kennelly M., Thiruchelvam N., Averbeck M.A., Konstatinidis C., Chartier-Kastler E., Trojgaard P., Vaabengaard R., Krassioukov A., Jakobsen B.P. Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections. Adv. Urol. 2019;2019:2757862. doi: 10.1155/2019/2757862. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous